Skip to content

Prediction of REsPonse to Antipsychotics using electRoEncephalography

Prediction of REsPonse to Antipsychotics using electRoEncephalography - PREPARE

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON52737
Enrollment
100
Registered
2020-10-15
Start date
2021-05-21
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Psychotic illness Schizophrenia

Interventions

None listed

Sponsors

Universitair Medisch Centrum Utrecht
Lead Sponsor

Eligibility

Age
16 Years to 64 Years

Inclusion criteria

Inclusion criteria: - Age between 16 and 55 years old - Psychotic episode - Patients who are going to start or recently have started antipsychotic treatment (

Exclusion criteria

Exclusion criteria: - Coercive measures. With exception of "zorg machtiging" if a patient wants to start with antipsychotics voluntarily and the patient is competent of making decisions. - A history of mental retardation - Organic brain damage - Organic psychosis - Patients who are pregnant or patients who are breastfeeding.

Design outcomes

Primary

MeasureTime frame
For the primary outcome, patients will be divided into a responder and a non-responder group based on the Positive and Negative Symptoms Scale (PANSS) scores and remission criteria as defined by Andreasen and others. *

Secondary

MeasureTime frame
Secondary outcomes include improvement on questionnaires for the quality of life, general and physical health and functional outcome. Tertiary outcome includes continuous changes in psychosis symptom levels as measured by the PANSS.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)